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Definitions and Methodology for the Grayscale
and Radiofrequency Intravascular Ultrasound
and Coronary Angiographic Analyses
Akiko Maehara, MD,* Ecaterina Cristea, MD,* Gary S. Mintz, MD,* Alexandra J. Lansky, MD,†
Ovidiu Dressler, MD,* Sinan Biro, MSC,* Barry Templin, MBA,‡ Renu Virmani, MD,§
Bernard de Bruyne, MD, PHD, Patrick W. Serruys, MD, PHD,¶ Gregg W. Stone, MD*
New York, New York; New Haven, Connecticut; Santa Clara, California; Gaithersburg, Maryland;
Aalst, Belgium; and Rotterdam, the Netherlands
O B J E C T I V E S In a prospective study of the natural history of coronary atherosclerosis using
angiography and grayscale and radiofrequency intravascular ultrasound (IVUS)–virtual histology (VH),
larger plaque burden, smaller luminal area, and plaque composition thin-cap fibroatheroma emerged as
independent predictors of future adverse cardiovascular events.
B A C KG ROUND The methodology for IVUS-VH classification for an in vivo natural history study and
the prospective image mapping by angiography and grayscale and IVUS-VH have not been established.
METHOD S All culprit and nonculprit lesions (defined as 30% angiographic visual diameter stenoses)
were analyzed. Three epicardial vessels as well as all 1.5-mm-diameter side branches were divided into 29
CASS (Coronary Artery Surgery Study) segments. Each CASS segment was then subdivided into 1.5-mm-long
subsegments, and dimensions were analyzed. All grayscale and IVUS-VH slices from the proximal 6 to 8 cm
of the 3 coronary arteries were analyzed, with lesions defined as havingmore than 3 consecutive sliceswith40%
plaque burden categorized as: 1) VH thin-cap fibroatheroma; 2) thick-cap fibroatheroma; 3) pathological intimal
thickening; 4) fibrotic plaque; or 5) fibrocalcific plaque. The locations of angiographic and grayscale and IVUS-VH
lesions were recorded in relation to the corresponding coronary artery ostium and nearby side branches.
R E S U L T S The 3-year cumulative rate of major adverse cardiovascular events was 20.4%. Events were
adjudicated to culprit lesions in 12.9% of patients and to nonculprit lesions in 11.6%. On multivariate
analysis, nonculprit lesions associated with recurrent events were characterized by a plaque burden
70% (hazard ratio: 5.03; 95% confidence interval: 2.51 to 10.11; p  0.0001), a minimal luminal area
4.0 mm2 (hazard ratio: 3.21; 95% confidence interval: 1.61 to 6.42; p  0.001), and IVUS-VH phenotype
of a thin-cap fibroatheroma (hazard ratio: 3.35; 95% confidence interval: 1.77 to 6.36; p  0.001).
CONC L U S I O N S Three-vessel multimodality coronary artery imaging was feasible and allowed the
identification of lesion-level predictors for future events in this natural history study. (J Am Coll Cardiol
Img 2012;5:S1–9) © 2012 by the American College of Cardiology Foundation
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S2T
he PROSPECT (Providing Regional Ob-
servations to Study Predictors of Events in the
Coronary Tree) study was a prospective trial
of the natural history of coronary atheroscle-
osis using angiography and radiofrequency intra-
ascular ultrasound (IVUS)–virtual histology (VH)
o identify the clinical and lesion-related factors
hat predict future coronary events (1). It was
erformed at 37 sites in the United States and
urope. Patients with acute coronary syndromes
See page S39
were enrolled after undergoing successful percutane-
ous coronary intervention (PCI) of all culprit lesions
responsible for the acute events. Angiography was
performed of the entire coronary tree, followed by
grayscale and IVUS-VH of the proximal 6
to 8 cm of all 3 epicardial arteries. All baseline
angiograms and grayscale and IVUS-VH im-
ages were prospectively analyzed without
knowledge of subsequent events using pre-
specified definitions and methodology. Plaque
burden and luminal area as prospectively mea-
sured by grayscale IVUS and plaque composi-
tion as assessed by IVUS-VH were deter-
mined to be independent predictors of future
adverse cardiovascular events (1).
The main results of the PROSPECT
study were as follows. The 3-year cumu-
lative rate of major adverse cardiovascular
events was 20.4%. Events were adjudi-
cated to culprit lesions in 12.9% of pa-
tients and to nonculprit lesions in 11.6%.
On multivariate analysis, nonculprit le-
sions associated with recurrent events were
characterized by a plaque burden 70%
hazard ratio: 5.03; 95% confidence interval: 2.51 to
0.11; p  0.0001), a minimal luminal area  4.0
m2 (hazard ratio: 3.21; 95% confidence interval:
1.61 to 6.42; p 0.001), and IVUS-VH phenotype of
a thin-cap fibroatheroma (TCFA) (hazard ratio: 3.35;
95% confidence interval: 1.77 to 6.36; p  0.001).
The purpose of this report is to provide de-
tailed information about the methodology used in
PROSPECT that arrived at these findings. All reports
presented in this issue of iJACC (2–9) used uniform
ethodology and classification as outlined in this report.
M E T H O D S
Coronary angiography. Coronary angiography be-
und
y
mafore PCI, immediately after PCI, and at follow-up p(at the time of the event) were performed in at least
2 orthogonal views after the administration of
intracoronary nitroglycerin.
3-vessel qualitative and quantitative angiographic
analysis. All angiograms were analyzed prospec-
tively at an independent angiographic core labora-
tory at the Cardiovascular Research Foundation
(CRF) (New York, New York) that was blinded to
the IVUS analysis and to the clinical events. Quan-
titative analysis was performed using proprietary
methodology modified from Medis CMS software
version 7.0 (Medis Medical Imaging Systems, Le-
iden, the Netherlands) that was first validated in 78
randomly selected coronary segments (data on file
at the CRF). Qualitative analysis using standard
definitions (10) included thrombus, ulceration, in-
timal flap, aneurysm, tortuosity, angulation, calcifi-
cation, and eccentricity. Post-PCI qualitative anal-
yses included abrupt closure, ectasia, luminal
irregularities, intimal flap, thrombus, dissection,
perforation, side branch loss, distal embolization,
and coronary spasm. The longitudinal extension of
each of these morphologies was recorded in relation
to the distance from the coronary ostium. For each
vessel, Thrombolysis In Myocardial Infarction
(TIMI) flow, TIMI frame count, corrected TIMI
frame count, and myocardial blush score were
recorded before PCI, after PCI, and at follow-up.
First, all culprit and nonculprit lesions (defined as
30% visual diameter stenosis) were identified and
their locations recorded in relation to the corre-
sponding coronary artery ostium and nearby side
branches.
Second, all culprit and nonculprit lesions before
PCI, culprit lesions after PCI, and lesions causing
events during follow-up were analyzed, including
minimal luminal diameter, lesion length, mean refer-
ence vessel diameter (obtained by averaging 5-mm
segments proximal and distal to the target lesion
location), and diameter stenosis ([1  minimal lumi-
nal diameter/reference vessel diameter]  100).
Third, all 3 epicardial vessels as well as all
1.5-mm-diameter side branches were divided into
29 CASS (Coronary Artery Surgery Study) seg-
ments. Each CASS segment was then subdivided
into 1.5-mm-long subsegments (Fig. 1) and ana-
lyzed. Measurements of each 1.5-mm-long subseg-
ment included minimal luminal diameter, interpo-
lated reference vessel diameter, and diameter
stenosis.
Grayscale and IVUS-VH image acquisition. Immedi-
tely after PCI, grayscale and IVUS-VH wereA B B R E V I A T I O N S
A N D A C R O N YM S
CSA cross-sectional area
DC dense calcium
EEM external elastic
membrane
IVUS intravascular ultraso
NC necrotic core
PCI percutaneous coronar
intervention
PIT pathological intimal
thickening
TCFA thin-cap fibroathero
ThCFA thick-cap
fibroatheroma
TIMI Thrombolysis In
Myocardial Infarctionerformed within the left main coronary artery and
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S3proximal 6 to 8 cm of each major epicardial coro-
nary artery using a synthetic aperture array, 20-
MHz, 3.2-F catheter (Eagle Eye, Volcano Corpo-
ration, Rancho Cordova, California) after the
administration of intracoronary nitroglycerin. The
IVUS catheter was advanced distal to the region of
interest, the guiding catheter was disengaged, and
the IVUS catheter was pulled backed to the aorto-
ostial junction using an R-100 motorized catheter
pullback system (0.5 mm/s). During pullback, gray-
scale IVUS images were recorded, raw radiofre-
quency data were captured at the top of the R wave,
and the reconstruction of the color-coded map by
an IVUS-VH data recorder was performed (In-
Vision Gold, Volcano Corporation). IVUS studies
were archived onto CD-ROMs or DVDs.
Grayscale and IVUS-VH analysis. Off-line grayscale
nd IVUS-VH analyses of all imaged segments
ere performed prospectively at an independent
VUS core laboratory at the CRF that was blinded
o the angiographic analysis and to the clinical
vents using: 1) QCU-CMS software (Medis Med-
cal Imaging Systems) for contouring; 2) pcVH
ersion 2.1 software (Volcano Corporation) for
ontouring and data output; and 3) proprietary
VH software (developed and validated at the
RF) for qualitative segmental assessment and
uantitative data output. External elastic membrane
Figure 1. Example of Angiographic Analysis
(A) Left main and left anterior descending coronary artery CASS (Co
quantitative analysis of segment 13 and its mid lesion. (C) Quantita
Regional Observations to Study Predictors of Events in the Coronar
(D) Output of the angiographic analysis of PROSPECT. The x-axis sh
and its 1.5-mm-long subsegments. The y-axis shows the luminal diaEEM) and luminal borders were contoured for bach slice (median interslice distance 0.40 mm).
uantitative IVUS measurements included EEM
ross-sectional area (CSA), luminal CSA, plaque
nd media (EEM minus luminal) CSA, and plaque
urden (plaque and media divided by EEM).
VUS-VH plaque components were color coded as
ense calcium (DC) (white), necrotic core (NC)
red), fibrofatty (light green), or fibrous tissue (dark
reen) and reported as CSA and percents of total
laque CSA (11–13). Volumes were calculated
sing Simpson’s rule and reported as total volume
nd normalized area (volume divided by length).
he slice with the minimal luminal CSA and the
lice with maximal NC CSA were identified and
ssessed as well. The remodeling index was calcu-
ated by the EEM CSA at the minimal luminal
SA or maximal NC slice divided by the average of
he proximal and distal reference EEM CSA. Qual-
tative grayscale IVUS morphology included plaque
upture (intraplaque cavity that communicated with
he lumen with an overlying residual fibrous cap
ragment) and echolucent plaque (a plaque contain-
ng a non–echo-reflective dark zone). Because the
eft main coronary artery was usually imaged during
oth left anterior descending and left circumflex
oronary artery pullbacks, the run with better left
ain image quality was chosen. Similarly, when a
roximal vessel was imaged during pullbacks from
ary Artery Surgery Study) segments (CASS 11 to 14). (B) Typical
angiographic analysis developed for PROSPECT (Providing
ee); segment 13 was divided into 1.5-mm-long subsegments.
the distance from the proximal to the distal end of this segment
ter for each subsegment.ron
tive
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owsoth the distal main vessel and a major side branch,
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S4the run with better proximal vessel image quality
was chosen.
IVUS-VH classification. IVUS-VH phenotype was
classified as: 1) VH TCFA; 2) thick-cap fibroathe-
roma (ThCFA); 3) pathological intimal thickening
(PIT); 4) fibrotic plaque; and 5) fibrocalcific plaque.
Fibrotic plaque had mainly fibrous tissue, with
10% confluent NC, 10% confluent DC, and
15% fibrofatty plaque. Fibrocalcific plaque had
mainly fibrous tissue, with10% confluent DC but
10% confluent NC. PIT had a mixture of all
plaque components but predominantly fibrofatty
plaque, with 10% confluent NC and 10% con-
fluent DC (Fig. 2).
Fibroatheroma (both VH TCFA and ThCFA)
was defined as 10% confluent NC (spotty red
color was not considered confluent NC) (Fig. 3).
Because the resolution of IVUS-VH is 150 to 250
m, it was not possible to detect fibrous cap
thickness65 m (the typical pathologic definition
f a thin fibrous cap). Therefore, if there was 30°
f NC abutting to the lumen in three consecutive
lices, the fibroatheroma was classified as VH
CFA; otherwise, it was classified as ThCFA.
VUS-VH often contains a 1-pixel thickness of
hite separating the NC from the luminal surface
hat is considered to be an artifact; this was included
n the qualitative assessment of NC. The total NC
Figure 2. IVUS-VH Phenotype Classification
Typical intravascular ultrasound (IVUS)–virtual histology (VH) examp
(ThCFA), pathological intimal thickening (PIT), fibrotic plaque, and fi
side of dense calcium (DC) (A) or no DC (B) and DC superficial to N
subdivided into single FA (E) or multiple FA (layered multiple [F] or circbutting the lumen including the isolated nonred
ixels was measured in degrees (Fig. 3).
Fibroatheromas were subclassified as having sin-
le or multiple confluent NCs (circumferential or
ayered) and containing or not containing DC (Fig. 2).
ecause DC caused shadowing and may have af-
ected IVUS-VH plaque classification, we reported
C in relation to the NC: DC superficial to NC,
C inside of NC, or DC outside of NC. For this
urpose, grayscale IVUS was evaluated together
ith IVUS-VH to assess the presence and extent of
hadowing from calcification.
Thus, all individual image slices were evaluated
egarding: 1) existence of fibroatheroma (10%
onfluent NC); 2) existence of a fibrous cap;
) single or multiple NCs (layered or circumferen-
ial); and 4) presence of DC and its relation with
C (superficial to NC, inside of NC, or outside of
C). An overall hierarchy of fibroatheroma sub-
ypes was pre-specified as follows (on the basis of
heir anticipated likelihood to be correlated with
uture adverse events):
1. VH TCFA, multiple confluent NC, DC out-
side of NC
2. VH TCFA, multiple confluent NC, no DC
3. VH TCFA, single confluent NC, DC outside
of NC
of VH thin-cap fibroatheroma (TCFA), thick-cap fibroatheroma
calcific plaque. ThCFA was subdivided into necrotic core (NC) out-
) or DC inside of NC (D), respectively. Fibroatheroma (FA) wasles
bro
C (Cumferential multiple [G]).
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S54. VH TCFA, single confluent NC, no DC
5. ThCFA, multiple confluent NC, DC outside
of NC
6. ThCFA, multiple confluent NC, no DC
7. ThCFA, single confluent NC, DC outside of NC
8. ThCFA, single confluent NC, no DC
9. ThCFA, multiple confluent NC, DC superfi-
cial to NC or inside of NC
10. ThCFA, single confluent NC, DC superficial
to NC or inside of NC
These 10 fibroatheroma subtypes were divided into
3 main groups 1) VH TCFA (subtypes 1 to 4), 2)
noncalcified ThCFA (subtypes 5 to 8), and 3)
calcified ThCFA (subtypes 9 and 10).
Lesion-level and fibroatheroma-level analysis. In ad-
dition to vessel data and overall patient data, we
constructed the grayscale and IVUS-VH data at 3
levels: lesion level, fibroatheroma level, and slice level
(Fig. 4). A lesion was defined as a segment in which
3 consecutive slices had 40% plaque burden.
esions were considered separate if there was a 5-
m-long normal segment with 40% plaque burden
Figure 3. Nonconfluent and Confluent NC and VH TCFA
Nonconfluent necrotic core (NC) typically appeared as spotty red co
tinuous red color (white arrow). A typical virtual histology (VH) thin
lumen of 50° (angle); this NC contained an occasional white or othe
Figure 4. Three Levels of Grayscale and IVUS-VH
The arrows associated with the blue line indicate consecutive intra
slice contains unique IVUS data. The 3 green lines indicate that thi
cate that each lesion contains more than 1 nonoverlapping fibro
noncalcified-cap fibroatheroma (red), or calcified-cap fibroatheroma
black) such as plaque rupture or echolucent plaque was also mapp
lines), and to the fibroatheromas (yellow, red, or orange lines).etween them. For lesion level IVUS-VH classification,
he entire lesion was evaluated.
A lesion could contain more than 1 fibroatheroma.
he main fibroatheroma groups (VH TCFA, noncal-
ified ThCFA, and calcified ThCFA) required 3
onsecutive slices demonstrating the same main fibro-
theroma subtype. Fibroatheromas were considered
ultiple and distinct if they were separated by 3
onsecutive image slices containing a different fibro-
theroma subtype (VH TCFA, noncalcified ThCFA,
r calcified ThCFA) or nonfibroatheroma phenotype;
or example, multiple VH TCFAs were considered
eparate if they were separated by 3 consecutive
on–VH TCFA–containing image slices. Then, the
broatheroma subtype (1 to 10 as specified previously)
as assigned on the basis of the maximum NC slice.
rayscale morphology (plaque rupture and echolu-
ent plaque) was also mapped at the fibroatheroma
evel.
In lesions with more than 1 fibroatheroma sub-
ype, for the lesion level VH classification, the
reviously described hierarchy was used; a VH
CFA took precedence over a ThCFA, and any
(black arrows) in the plaque. Confluent NC had a thick and con-
fibroatheroma (TCFA) included an arc of abutting NC to the
nred pixel within the abutting NC (white arrow).
ular ultrasound (IVUS) image slices within a vessel segment; each
ment contains 3 lesions. The yellow, red, and orange lines indi-
roma: virtual histology (VH) thin-cap fibroatheroma (yellow),
ange), respectively. Grayscale morphology (shown in gray or
o the overall segment (blue line), to individual lesions (greenlor
-capvasc
s seg
athe
(or
ed t
G
s
b
m
b
M
r
s
s
a
A
a
T
r
t
(
i
0
1
fi
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 3 , S U P P L S , 2 0 1 2
M A R C H 2 0 1 2 : S 1 – 9
Maehara et al.
Definitions and Methodology in the PROSPECT Study
S6fibroatheroma took precedence over any nonfibro-
atheroma. If there was no fibroatheroma in the
entire lesion, the VH classification at the minimal
luminal area site was evaluated and defined as
fibrotic plaque, fibrocalcific plaque, or PIT.
Coregistration with IVUS-VH and identification of lesions
responsible for nonculprit events. All angiographic
and grayscale and IVUS-VH analyses were per-
formed independently. Grayscale and IVUS-VH anal-
yses of all imaged epicardial vessels were coregis-
tered to the angiographic roadmap using fiduciary
side branches for alignment (Fig. 5) with interpo-
lation as necessary to account for different length
measurements to define and match the 1.5-mm-
long angiographic and grayscale and IVUS-VH
slices and subsegments. Lesions responsible for
events were identified using the follow-up angio-
gram, and then the corresponding segments and
subsegments were matched side by side to the baseline
angiograms and their corresponding baseline grayscale
and IVUS-VH images in terms of both quantitative
and qualitative morphologic analysis (Fig. 6).
D I S C U S S I O N
Development of definitions. Previous angiographic
Figure 5. Coregistration Between Angiography and IVUS
Angiographic and intravascular ultrasound (IVUS) segments were m
nal branch; D2  second diagonal branch; LCX  left circumflex co
rator; S3  third septal perforator.natural history studies, such as CASS, demon- astrated that patients with normal coronary arteries
have a relatively benign prognosis. Like PROSPECT,
CASS defined normal coronary arteries as having
30% diameter stenosis by visual estimation (14,15).
lagov et al. (16) described the concept of “compen-
ated remodeling” and concluded that compensation
y vessel enlargement failed and luminal encroach-
ent began when plaque accumulation (i.e., plaque
urden) exceeded (on average) 40% of EEM area.
any plaque regression and progression studies have
eported an average overall plaque burden in the study
egments of approximately 40% (17,18). Many IVUS
ubstudies of interventional trials have reported an
verage reference segment plaque burden of 40% (19).
gain, this justifies the use of a plaque burden of 40%
s the minimal threshold to define a lesion.
The minimal reported length of a pathologic
CFA is 1 to 2 mm (20–22). Antegrade or
etrograde movement of an IVUS catheter during
he systolic and diastolic cycle averages 1.5 mm
23). In past studies, the average interslice distance
n the electrocardiographically gated VH images was
.5 mm. For these reasons, PROSPECT used a
.5-mm (or 3 image slice) minimal length for any
nding such as plaque burden 40%, VH TCFA,
ed using side branches as fiduciary landmarks. D1  first diago-
ary artery; S1  first septal perforator; S2  second septal perfo-atch
ronnd so on.
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S7The IVUS-VH phenotype classification is based
on the modified American Heart Association clas-
sification, excluding adaptive intimal thickening,
intimal xanthoma, and fatty streaks, because these
are typically present only in arteries with 40%
plaque burden (20). In addition, the next most
common high-risk lesion morphology, plaque ero-
sion, cannot be reliably detected by IVUS, because
of its limited resolution. Therefore, for IVUS-VH
classification, only the following phenotypes were
considered: 1) TCFA; 2) ThCFA; 3) PIT; 4) fibrotic
plaque; and 5) fibrocalcific plaque. Pathologically,
the key difference between PIT and fibroatheroma
is the presence of an NC. Therefore, to define
fibroatheroma, we chose the presence of confluent
NC 10% because Virmani et al. (20,21) and
Cheruvu et al. (22) reported that the amounts of
overall NC for TCFA, ThCFA, and stable plaque
were 23  17%, 15  20%, and 12  25%.
IVUS-VH–related issues. The accuracy of IVUS-VH
analysis behind calcium continues to be debated and
probably depends on the thickness, density, and
amount of calcium. However, it is unclear how
often there is a definable signal compared with
Figure 6. Example of a Lesion With a Nonculprit MACE
At baseline, a 58-year-old man presented with a non–ST-segment e
nary artery was treated. All 3 vessels were imaged, and the angiogr
for the left anterior descending coronary artery at baseline are show
with coronary angiography showing total occlusion of the mid left
sponding baseline IVUS-VH images for the lesion causing the noncu
showed a thin-cap fibroatheroma with a minimal luminal cross-sectionamostly noise behind calcium from images obtained
in vivo. In cases with grayscale shadowing, VH
often shows red color, which is in fact an artifact.
We did not exclude data behind grayscale calcifica-
tion, which may have introduced errors.
There is currently no specific VH algorithm to
identify thrombus (11–13). Thus, thrombus ap-
pears green or light green (fibrotic or fibrofatty
plaque) depending on its age. In the VH analysis
in PROSPECT, no attempt was made to identify
thrombus and to exclude it from the overall plaque
area. Therefore, thrombus could cause a TCFA to
be misclassified as a ThCFA.
Data acquisition issues. As previously reported, of
697 enrolled patients, grayscale and IVUS-VH
images were available for 673 and 623 patients,
respectively (1). Grayscale IVUS images were not
available in 24 patients, because: 1) the core lab
never received any IVUS image media (n  17);
2) there was too much noise in the IVUS images
(n  4); 3) pullback length was inadequate (n  2);
and 4) there were problems with the digital media
(n 1). IVUS-VH images were not available for 50
patients, because of: 1) failure to capture IVUS-VH
tion myocardial infarction, and the culprit lesion in the right coro-
and intravascular ultrasound (IVUS)–virtual histology (VH) images
One year later, the patient was rehospitalized for unstable angina,
rior descending coronary artery (S3 on the angiogram). The corre-
t major adverse cardiac event (MACE) (mid lesion, IVUS-VH image A)
2leva
ams
n.
ante
lpril area of 3.6 mm .
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S8data (n  28, in whom only grayscale IVUS was
received); 2) too much noise (n 6), segmental loss
of VH (n  4), or other catheter-related problems
(n 3); and 3) digital media–related problems (n
9). Eleven patients (1.6%) had complications that
were attributed to 3-vessel intravascular imaging.
Mostly, these complications occurred in the early
stages of the trial during the learning curve.
Both the angiographic and IVUS-VH analyses
were time consuming. Even when performed by
experienced analysts and overread by experienced
physicians, the angiographic analysis for the entire
coronary tree required at least 1 day per patient, and
the grayscale and IVUS-VH analysis required on
average 1 day per vessel (mean 2.3 days per patient).
Thus, given the software that was available at the
time of this study, the total manpower required for
the complete PROSPECT analysis was estimated to be
2,400 person-days. In addition, because the devel-
opment of IVUS-VH algorithm and analysis soft-
ware continued during the trial, several reanalyses
were performed. The size of the entire image set for
697 patients was 1.5 terabytes (2.1 gigabytes/
patient). During the analysis process to protect the
data, multiple image files were kept on an active
server with regular backup; this required approxi-
mately 6 terabytes of storage space.
Comparison with other technologies and future
directions. There are 2 other radiofrequency IVUS
analytic techniques available: iMAP (Boston Scien-
tific Corporation, Natick, Massachusetts) and inte-
grated backscatter IVUS. Each of the 3 IVUS tissue
characterization techniques uses a different algo-
rithm, tissue color coding, and analysis scheme, and
there is no uniform methodology or standard for
reporting the results of IVUS-derived plaque com-
position, making direct comparisons difficult. In
addition, there are also structural and compositionalSerruys PM, et al. Relationship be- disease presentingmography and near infrared spectroscopy); in par-
ticular, the resolution of optical coherence tomog-
raphy will allow direct measurement of vulnerable
plaque fibrous cap thickness, something that was
not possible in PROSPECT. There are enough
differences among these diverse intravascular imag-
ing modalities to make it difficult to use the findings
of PROSPECT for any technology other than
IVUS-VH (24–28); each technology will probably
require its own PROSPECT-like study. Further-
more, even another natural history study using
IVUS-VH should be performed only after a reeval-
uation the image acquisition and analysis method-
ology and definitions used in PROSPECT.
Conversely, the systematic approach to integrat-
ing angiography, intravascular imaging, and clinical
follow-up as performed in PROSPECT should be
useful guidelines for any future study.
C O N C L U S I O N S
PROSPECT was a natural history study in patients
with acute coronary syndromes in which 3-vessel
angiography and grayscale and radiofrequency
IVUS were used to prospectively characterize 3,160
IVUS lesions and to identify the patient-related and
lesion-related predictors of events. Accomplishing
this required the development of proprietary soft-
ware to permit coregistration of angiographic and
IVUS images and detailed analysis at a level not
previously attempted. Future software iterations
should allow these processes to be automated and
streamlined, reducing their complexity and person-
nel burden, thereby facilitating future natural his-
tory studies and drug and device therapy trials.
Reprint requests and correspondence:Dr. Akiko Maehara, Car-
iovascular Research Foundation, 111 East 59th Street, Newoptical imaging techniques (optical coherence to- York, New York 10022. E-mail: amaehara@crf.org.R E F E R E N C E S
1. Stone GW, Maehara A, Lansky AJ, et
al. A prospective natural history study
of coronary atherosclerosis. N Engl
J Med 2011;364:226–35.
2. Wykrzkowska JJ, Mintz GS, Garcia-
Garcia HM, et al. Longitudinal distri-
bution of plaque burden and necrotic
core–rich plaques in nonculprit lesions
of patients presenting with acute coro-
nary syndromes. J Am Coll Cardiol Img
2012;5 Suppl S:S10–8.
3. Brugaletta S, Garcia-Garcia HM,tween palpography and virtual histol-
ogy in patients with acute coronary
syndromes. J Am Coll Cardiol Img
2012;5 Suppl S:S19–27.
4. Marso SP, Mercado N, Maehara A, et
al. Plaque composition and clinical out-
comes in acute coronary syndrome pa-
tients with metabolic syndrome or dia-
betes. J Am Coll Cardiol Img 2012;5
Suppl S:S42–52.
5. Baber U, Stone GW, Weisz G, et al.
Coronary plaque composition, mor-
phology, and outcomes in patients
with and without chronic kidneywith acute coro-nary syndromes. J Am Coll Cardiol
Img 2012;5 Suppl S:S53– 61.
6. Lansky AJ, Ng VG, Maehara A,
et al. Gender and the extent of
coronary atherosclerosis, plaque
composition and clinical outcomes
in acute coronary syndromes. J Am
Coll Cardiol Img 2012;5 Suppl S:
S62–72.
7. McPherson JA, Maehara A, Weisz G,
et al. Residual plaque burden in pa-
tients with acute coronary syndromes
after successful percutaneous coronary
intervention. J Am Coll Cardiol Img
2012;5 Suppl S:S76–85.
11
1
1
2
2
2
2
2
2
2
2
2
a
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 3 , S U P P L S , 2 0 1 2
M A R C H 2 0 1 2 : S 1 – 9
Maehara et al.
Definitions and Methodology in the PROSPECT Study
S98. Brener SJ, Mintz GS, Cristea E, et al.
Characteristics and clinical signifi-
cance of nonculprit, angiographically
mild lesions in acute coronary syn-
dromes. J Am Coll Cardiol Img
2012;5 Suppl S:S86–94.
9. Sanidas EA, Mintz GS, Maehara A,
et al. Adverse cardiovascular events
arising from atherosclerotic lesions
with and without angiographic disease
progression. J Am Coll Cardiol Img
2012;5 Suppl S:S95–105.
10. Popma JJ, Almonacid A, Lansky AJ.
Qualitative and quantitative coronary
angiography. In: Topol EJ, editor.
Textbook of Interventional Cardiol-
ogy. Philadelphia, PA: Saunders,
2008:1071–93.
11. Nair A, Kuban B, Tuzcu M, et al.
Coronary plaque classification with
intravascular ultrasound radiofre-
quency data analysis. Circulation
2002;106:2200–6.
12. Nair A, Margolis P, Kuban B, et al.
Automated coronary plaque charac-
terization with intravascular ultra-
sound backscatter: ex vivo validation.
Eurointervention 2007;3:113–20.
13. Garcı´a-Garcı´a HM, Mintz GS, Ler-
man A, et al. Tissue characterization
using intravascular radiofrequency
data analysis: recommendations for
acquisition, analysis, interpretation
and reporting. Eurointervention 2009;
5:177–89.
14. Ellis S, Alderman E, Cain K, et al.
Prediction of risk of anterior myocar-
dial infarction by lesion severity and
measurement method of stenoses in
the left anterior descending coronary
distribution: a CASS registry study.
J Am Coll Cardiol 1988;11:908–16.15. Kemp HG, Kronmal RA, Vlietstra
RE, et al. Seven year survival of pa-tients with normal or near normal
coronary arteriograms: a CASS regis-
try study. J Am Coll Cardiol 1986;7:
479–83.
6. Glagov S. Weisenberg E, Zarins CK,
et al. Compensatory enlargement of
human atherosclerotic coronary arter-
ies. N Eng J Med 1987;316:1371–5.
7. Nissen ES, Tuzcu EM, Schoenhagen
P, et al. Effect of intensive compared
with moderate lipid-lowering therapy
on progression of coronary atheroscle-
rosis. JAMA 2004;291:1071–80.
8. Nissen ES, Tradif JC, Nicholls SJ, et
al. Effect of torcetrapib on the pro-
gression of coronary atherosclerosis.
N Eng J Med 2007;356:1304–16.
9. Mintz GS, Painter JA, Pichard AD,
et al. Atherosclerosis in angio-
graphically “normal” coronary artery
reference segments: an intravascular
ultrasound study with clinical corre-
lations. J Am Coll Cardiol 1995;25:
1479 – 85.
0. Virmani R, Kolodgie FD, Burke AP,
Farb A, Schwartz SM. Lessons from
sudden coronary death. A comprehen-
sive morphological classification
scheme for atherosclerotic lesions. Ar-
terioscler Thromb Vasc Biol 2000;20:
1262–75.
1. Virmani R, Bruke AP, Farb A,
Kolodgie FD. Pathology of the vul-
nerable plaque. J Am Coll Cardiol
2006;47:C13–8.
2. Cheruvu PK, Finn AV, Gardner C, et
al. Frequency and distribution of thin-
cap fibrotatheroma and ruptured
plaques in human coronary arteries.
J Am Coll Cardiol 2007;50:940–9.
3. Arbab-Zadeh A, DeMaria AN,
Penny WF, et al. Axial movement of
the intravascular ultrasound probe
during the cardiac cycle: implica- utions for three-dimensional recon-
struction and measurements of cor-
onary dimensions. Am Heart J 1999;
138:865–72.
4. Sawada T, Shite J, Garcia-Garcia
HM, et al. Feasibility of combined use
of intravascular ultrasound radiofre-
quency data analysis and optical co-
herence tomography for detecting
thin-cap fibroatheroma. Eur Heart J
2008;29:1136–46.
5. Goderie TP, van Soest G, Garcia-
Garcia HM, et al. Combined optical
coherence tomography and intravas-
cular ultrasound radio frequency data
analysis for plaque characterization.
Classification accuracy of human cor-
onary plaques in vitro. Int J Cardio-
vasc Imaging 2010;26:843–50.
6. Kubo T, Nakamura N, Matsuo Y, et
al. Virtual histology intravascular ul-
trasound compared with optical co-
herence tomography for identification
of thin-cap fibroatheroma. Int Heart J
2011;52:175–9.
7. Okubo M, Kawasaki M, Ishihara Y, et
al. Tissue characterization of coronary
plaques: comparison of integrated
backscatter intravascular ultrasound
with virtual histology intravascular ul-
trasound. Circ J 2008;72:1631–9.
8. Shin ES, Garcia-Garcia HM, Ligth-
art JM, et al. In vivo findings of tissue
characteristics using iMap IVUS and
virtual histology IVUS. Eurointerven-
tion 2011;6:1017–9.
Key Words: acute coronary
syndromes y coronary
ngiography y intravascular
ltrasound
